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Abstract
Brittany D. Rhoades, MSN, APRN, CCNS, CCTN
Left Ventricular Assist Device Adjustment Impacted by Assigned Patient
Trajectory (LVAD-ADAPT): A Qualitative Exploratory Study
May, 2020
Background: Left Ventricular Assist Devices (LVADs) are used as an advanced therapy
for advanced heart failure in order to sustain patients until a heart transplant is available
(bridge to transplant, ‘BTT’) or until the end of life (destination therapy, 'DT'). Despite
the differences in treatment trajectory, BTT and DT patients receive the same education.
Currently, it is unknown how the two groups compare to living with the LVAD regarding
the adjustment process.
Aims: This study aimed to explore LVAD patient experience, describe how patients
construct the impact of the LVAD on daily life and self-care, and compare the findings
between BTT and DT patients. It is imperative to understand how BTT and DT LVAD
recipients construct the patient experience in order to provide patient-centric education
for each group and promote optimal adjustment.
Methods: The study used a general qualitative methodology with a purposeful sampling
of 20 LVAD recipients who self-reported as either BTT or DT. Atlas.ti V8 was used to
manage transcribed interview data. Data content was analyzed, redundancy achieved,
relevant themes identified through content analysis, and exemplars noted.
Findings: Participants reported the overarching theme, Living with an LVAD is
inconvenient, but life-sustaining. BTT and DT LVAD participants contrasted the LVAD
patient experience in three phases, (1) illness perception, (2) LVAD adjustment, and (3)
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health aspirations. Six components emerged as necessary to LVAD adjustment among
both groups: (1) physical ability, (2) caregiver dependence, (3) self-care, (4) roles, (5)
LVAD public perception, and (6) connection. LVAD participants described differences in
health aspirations based on the self-reported LVAD indication.
Conclusions: BTT and DT LVAD patients experienced a similar adjustment to the
device. Despite the inconveniences of living with the LVAD, participants reported being
grateful for the extended life. If faced with having to live with the LVAD for the
remainder of life, most participants reported that it would not bother them, or they would
be able to adjust. Increased knowledge regarding BTT and DT patient experience is
required to develop patient-centric education and resources to ensure optimal LVAD
adjustment.
Keywords: Left Ventricular Assist Device (LVAD), Adjustment, Heart Failure,
Qualitative Research
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Summary of the Study
The purpose of the summary of the research study is to provide an overview of
the study and to guide the readers through each section of the dissertation. The study
proposal provides the specific aims, the background and the significance, the research
design and methods, and information regarding the protection of research participants.
The bibliography completes the dissertation proposal.
Two manuscripts, a review of the literature focusing on the current knowledge of
influencing factors on LVAD adaptation (Manuscript A), and the primary findings of the
current research study (Manuscript B) are included.
Manuscript A, Influencing Factors on Left Ventricular Assist Device Adaptation:
A Systematic Review, identified a need to expand research among the LVAD population
regarding all the influencing factors of adaptation. The review identified the patient
centric influencing factors on LVAD adaptation and organized under the four categories
(physiologic-physical, self-concept/group identity, interdependence, role function)
identified by Roy’s Adaptative Model (RAM). Emotional factors that did not clearly
relate to any of the four RAM categories were associated with the patient as a biopsycho-social being, an assumption of the RAM model. A comprehensive assessment and
understanding of influencing factors from the patients’ perspective are necessary to
provide holistic LVAD care.
Manuscript B, Left Ventricular Assist Device Adjustment Impacted by Assigned
Patient Trajectory: A Qualitative Exploratory Study, identified the overarching theme
Living with an LVAD is inconvenient but life-sustaining. The model, Living with the
LVAD: A Second Change at Life, depicts three separate phases representing the LVAD
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patient experience, (1) illness perception, (2) LVAD adjustment, and (3) health
aspirations. Within the model, six components were identified that impacted LVAD
adjustment and the holistic self. The six components include (1) physical ability, (2)
caregiver dependence, (3) self-care, (4) roles, (5) LVAD public perception, and (6)
connection. The LVAD recipient's perceived LVAD trajectory (BTT or DT) influenced
the LVAD adaption process. The holistic person, as well as health aspirations, were most
heavily influenced by the perceived treatment trajectories and differed based on
perceived BTT treatment trajectory or perceived DT treatment trajectory. The LVAD
recipients that reported they were BTT expressed future motivations for heart
transplantation. Those that reported DT described future aspirations of LVAD device
longevity (e.g., support on LVAD therapy for more than ten years). Implications for
future research and patient education are included.
The appendixes contain the internal review board approval letters, protocol
document, and the curriculum vitae.
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Specific Aims
Heart failure (HF) affects approximately 8 million people in the United States
(US) and exceeds $53 billion in total annual medical costs (Heidenreich, et al., 2013).
Individuals diagnosed with end stage HF have an estimated survival rate of 50% (Rogers,
et al., 2014). Currently the superior treatment option for end-stage HF is heart
transplantation (Yusen, et al., 2013); however, due to the limited number of available
organs, left ventricular assist devices (LVADs) have become a life sustaining and
effective treatment option. Prior to LVAD implant, HF patients are assigned an implant
indication that communicates the device treatment trajectory.

There are two primary

indications for LVAD therapy: (1) increase survival until heart transplantation, “Bridgeto-Transplant” (BTT) or (2) manage HF symptoms until end of life, “Destination
Therapy” (DT) (Rogers, et al, 2014). Most often DT patients do not meet heart
transplant criteria due to age, increased body mass index (BMI), or compliance.
Currently almost half of those in the US implanted with a device are listed as DT
(Kirklin, et. al., 2014).
Living with an LVAD creates unique challenges and complexities due to the
internal and external equipment required to operate the device (Abshire, et al, 2016).
Some patients describe adjusting to the device as a “new reality” (Dwyer & Casida,
2016). However, it is unknown if the implant indication, BTT or DT, impacts the LVAD
patient adjustment. BTT patients must adhere to LVAD pre-scribed medical therapy for
a limited time until receiving a heart transplant. On the contrary, DT patients must adjust
to LVAD prescribed medical therapy and the external device components until end-oflife.
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LVAD patients are living greater than 10 years on a device and have an unknown
potential life expectancy. BTT and DT patients receive the same LVAD education and
follow the same self-care recommendations, despite the extreme differences in end of
treatment trajectories and the length of time they must be supported on the LVAD. To
understand the LVAD patient experience, researchers have utilized quality of life
surveys; however, scarce information is available concerning the experience of living
with an LVAD (Modica, et. al., 2014). More specifically, it is unknown if the implant
indication, BTT or DT, influences the patient experience and impact of the LVAD
on adjustment and self-care.
This study will use a focused, generic, qualitative design with group and
individual interviews. Group interviews will be divided by self-reported implant
indication, BTT or DT. This approach allows respondents to present personal
perspectives as well as respond to the perspectives of others with the same treatment
trajectory (Polit & Beck, 2012). The overall objective of the study is to explore the
patient BTT and DT LVAD experience. The study will achieve the following aims:
Aim 1: Describe the BTT and DT LVAD patient experience.
Aim 2: Describe how BTT and DT LVAD patients construct the impact of the
LVAD on daily life and self-care.
Aim 3: Compare the experience and impact of the LVAD on adjustment and selfcare between BTT and DT patients.
The knowledge gained from this study is expected to have an impact on how we
prepare and support LVAD patients from pre-implantation through the continuum of
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care. The study will describe how LVAD patients construct living with a device and the
adjustment process.
Research Strategy
Significance
LVADs are mechanical pumps that assist HF patients by unloading the left
ventricle. Approximately 2,000 patients are implanted annually in the United States (US)
(Kirklin, et al., 2014). Seventy-eight percent of LVAD recipients live for one year or
greater and almost 50% survive four years or greater on LVAD support (Kirklin, et al.,
2014). Due to the limited availability of hearts for transplant, BTT patients are waiting
longer on LVAD support while on the transplant list. The redesigned HeartMate II was
first implanted in 2003 (Frazier, et al., 2004) and the HeartWare in 2006
(Leibman, 2006). LVAD patients are living greater than 10 years on a device and have
an unknown potential life expectancy. Both the BTT and DT population are increasing.
Due to an increase in advanced HF patients that do not meet heart transplant criteria, it is
estimated 2.5-4.2% of the 8 million patients suffering from HF in the United States could
benefit from a LVAD (Kirklin, et al., 2014).
LVAD therapy is unique as compared to traditional HF management or other
medical therapies. The LVAD internal and external components contribute to the
complexities of adjusting to this treatment modality. The internal pump is implanted in
the left ventricle and attaches to the aorta to increase the cardiac output. The internal
pump is connected to external components through a set of wires that exits the abdomen
known as the driveline. The driveline connects to an electronic microprocessor, the
“controller”, that operates the LVAD. The controller must be connected externally to an
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AC power supply or a set of batteries always. The external LVAD components
significantly impact the patients’ activities of daily life (ADLs). Patients are not allowed
to participate in water activities that might place the device at risk for getting wet or
submerged (e.g., swimming, tub bathing, boating). LVAD implant centers and state laws
very regarding VAD patient’s ability to operate motor vehicles. Depending on the
physical requirements of an occupation or the employer’s comfort level with an LVAD, a
patient’s ability to return to work despite the physical recovery may vary. Patient’s
recount LVAD adjustment in distinct phases: “Pre-LVAD (the time from first discussions
for the device to surgery”, “Implant Hospitalization”, “Early Home Adaptation” and
“Late Home Adaptation” (Abshire, et al, 2016).
Review of the literature identifies some of the complexities of living with an
LVAD. In the hospital, the LVAD patient learns to care for the LVAD and manage
emergency alarms. Patients learn skills in the hospital related to the care of the LVAD.
Upon hospital discharge they must learn to incorporate these skills into the home
environment and daily activities (Casida, et al., 2011; Overgaard, et al., 2012; Sandau, et
al., 2014; Ottenberg, et al., 2014; Chapman et. al., 2007). During the “Early Home
Adaption” phase, patients work towards independence but are heavily dependent upon
the assistance of a support person for LVAD dressing changes, transportation, bathing,
among other self-care activities, which can be a source of frustration (Modica, et. al,
2014; Shapiro, Levin, & Oz, 1996). Often changes to the home environment, including
electrical work, are required to optimally support the LVAD. Psychological stressors
during this phase include alterations in body image due to surgical scars and LVAD
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driveline. Additional stressors include weekly clinic visits, testing, and travel to and from
appointments (Casida, et al., 2011; Ottenberg, et al., 2014).
During the “Late Home Adaptation” phase, patients report a change in their sense
of normalcy including the ability to incorporate the LVAD into daily activities such as
cooking, sleeping, and hygiene (Casida, et. al., 2011; Overgaard, et. al., 2012; Hallas, et.
al, 2009; Chapman, et. al., 2007). In this phase patients describe mixed emotions ranging
from fear of LVAD complications (Casida, et. al., 2011; Overgaard, et. al., 2012; and
Chapman, et. at. 2007) to an increasing confidence in self-care. Some patients report a
psychological transition from anxiety to gratitude towards the pump (Casida, et al., 2011;
Ottenberg, et al., 2014). Many describe the importance of returning to normalcy
(Overgaard, et al., 2012), but also describe the difficulty of returning to work and
resuming previous roles (Casida, et. al., 2011; Overgaard, et. al., 2012; Sandau, et. al.,
2014; Marcuccilli, et. al., 2011; Chapman, et. at. 2007). Personal and social aspects of
life can be significantly impacted by the LVAD. Intimacy often requires modifications to
accommodate the LVAD external equipment (Dwyer & Casida, 2016; Casida et. al.,
2009; Casida et. al., 2011).
LVAD self-care requirements are the same for BTT and DT patients. The main
differences in the two groups is the anticipated length of time on LVAD support and the
hope for a heart transplant. The length of time BTT and DT patients live with an LVAD
can vary dramatically. LVAD BTT patients generally live with the device for several
months, greater than six months to a couple of years. In contrast, DT patients can live
with a single device for greater than 10 years and longer if supported by consecutive
devices. For many BTT patients transplant represents freedom from external equipment
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and the ability to return to water activities. It is unknown if the length of time a patient
must live with an LVAD impacts the adjustment process or if patients adjust to the device
differently, adhere to medical therapy, or experience LVAD therapy differently based on
implant indication. Current qualitative literature fails to identify similarities and
differences in the BTT and DT LVAD patient experience and the impact on daily life and
self-care between the two groups.
Significance of the Expected Research Contribution
The information gained through the exploratory study will increase the
understanding of the complexities of living with a LVAD for BTT and DT patients. The
study will also compare the similarities and differences in BTT and DT patient
adjustment. This will provide a foundation that will be used to explore the influencing
factors that lead BTT to adjust to meet transplant criteria (e.g., quit smoking, lose weight,
increase medical therapy compliance). Future studies will also explore the patient
experience of BTT patients transitioned to DT (e.g., increase in body mass index,
noncompliance, increase in age). This study is the beginning of a research trajectory that
will be used as a guide to evaluate and improve LVAD patient experience, education,
improve LVAD nursing care and provide LVAD recommendations specific to implant
indication.
Innovation
Limited information is known as to the differences and similarities between
LVAD BTT and DT patient experiences and how each group adjusts. The status quo for
clinical practice is to use the same education approach for BTT and DT patients despite
the length of time the patient may be on LVAD support. Previous studies have explored
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LVAD patient experience patient may be on LVAD support at a single LVAD center,
utilized small sample sizes (n < 20), and have focused on one implant indication. No
studies have compared or contrasted the BTT and DT LVAD patient experience. The
proposed research study is innovative because it will be a multisite qualitative study and
will utilize group and individual interviews to compare patient experience among LVAD
BTT and DT patients.
Conceptual Framework
Callista Roy’s Adaptation Theory (1970) is a grand theory that focuses on the
individuals’ ability to adapt with the internal and external environment and will be used
to guide this research study. Roy’s Adaptive Model (RAM) is comprised of four key
components: person, health, environment, and nursing (Roy, 1970). A person is defined
as a bio-psycho-social being that is constant interaction with a changing environment.
Innate and acquired mechanisms are used to adapt. The model includes peoples as
individuals or groups (i.e., families, organizations, and communities). How the patient
interacts with the LVAD in the environment as well as influencing factors impact
adjustment and mechanisms of adaptation will also be assessed. Adaptation is
manifested in RAM by four interrelated modes of behavior: 1) physiological, 2) selfconcept, 3) role function, and 4) interdependence (McEwen & Willis, 2014).
Physiological includes the physical and chemical process involved in the function and
activities of living organisms. Self-concept refers to the psychological and spiritual
integrity, sense of unity, meaning, purposefulness of universe. Role function relates self
to others, specifically the roles on people in society filling their needs for social integrity.
Interdependence refers to the close relationships of people and their purpose, structure
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and development. Currently no study has assessed how patients are impacted by an
LVAD in the four modes of behavior. RAM aids in assessing the LVAD patient
experience from a broad and comprehensive perspective.
Approach
A basic qualitative design, with an interpretative approach will be used to explore and
describe LVAD patients’ experience (Green & Thorogood, 2014). The aims for this
research study are:
Aim 1: Explore the BTT and DT LVAD patient experience.
Aim 2: Describe how BTT and DT LVAD patient’s construct the impact of the LVAD
on daily life and self-care.
Aim 3: Compare the experience and impact of the LVAD on daily life and self-care
between BTT and DT patients.
It is the expectation that knowledge gained from this study will provide insight
into how clinical providers prepare and support LVAD patients from pre-implantation
through the continuum of their care. The research will provide a better understanding of
the patient experience and influence how LVAD patients can best be prepared for LVAD
in a manner that supports the patient’s specific implant indication and promotes
adjustment. A better understanding of the differences in BTT and DT patient experience,
including similarities and differences may allow for development of implant indication
specific information and optimize LVAD adjustment.
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Methods for Aims 1 - 3
Research Design. A basic qualitative design, with an interpretative approach will
be used to explore, describe, and compare LVAD patients’ experience (Green &
Thorogood, 2014).
Sample and Setting. To accurately describe influencing factors of adjustment in
both BTT and DT LVAD patients purposive sampling will be used. The PI will attempt
to obtain variation in demographics, such as ethnicity, education level, age, gender, type
of LVAD, and length of time supported by LVAD, in both groups. Extreme or deviant
case sampling and typical case sampling will also be utilized (Green & Thorogood,
2004). The sampling methods will provide extreme and typical influencing factors
affecting LVAD adaptation. The variety of demographics will provide perspectives
among the LVAD patients across the adaptation experience, thereby increasing the
credibility of the findings (Kuzel, 1999).
Participants will be interviewed until redundancy is reached in thematic content
and saturation achieved in the depth and breadth of the topics discussed (Green &
Thorogood, 2004). Therefore, based on other qualitative studies with in-depth interviews,
it is estimated that redundancy and saturation will occur between 20-30 participants
(Korstjens & Moser, 2018). The setting will be two LVAD programs located in a large
metropolitan area in Southeast Texas. The programs collectively implant LVAD in
approximately 200 LVADs annually and manage routine care for 300-400 collectively.
Group interviews will consist of patients from Baylor St. Luke’s Medical Center
(BSLMC) and Memorial Hermann (MH). Interviews will be conducted in quiet,
comfortable locations within The University of Texas Health Science Center (UTH) at
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Houston Cizik School of Nursing Center for Nursing Research to allow patients the
opportunity to speak openly without a relationship to the institution. If interviews are
unable to be conducted at UTH, alternative locations will be used (e.g. BSLMC and MH
conference room). Patients from both BSLMC and MH will be clustered by device
implant indication, BTT or DT, to allow patients, the opportunity to speak openly
concerning their experience during group interviews. Interviews will be scheduled in a
timely manner from the time of recruitment and convenient for interview participants.
Participant Recruitment. Study flyers will be placed in LVAD patient areas
(e.g. LVAD outpatient clinics, LVAD inpatient units, patient support group meetings
etc.). Clinical providers (e.g. Physicians, APRNs, LVAD Coordinators) will be asked to
assist in identifying patients that meet study inclusion criteria and identify patient implant
indication. Clinical providers will be asked to provide potential study participants flyers
and ask them to contact the researchers if the PI is not available to consent in person.
Prescreening and informed consent will occur in person in the LVAD clinics or via
telephone. The information will be maintained in a screening log. To adequately
represent both BTT and DT patients, the PI will attempt to recruit adequate numbers of
both groups. Once redundancy and saturation is reached in either the BTT or DT group,
recruitment will cease for the specific group and only patients with the non-saturated
group will be recruited. Inclusion criteria includes adult (age > 18 years), English
speaking, currently living with a HeartMate II, HeartMate 3, or HeartWare device, and
greater than 1-month post LVAD implantation.
Potential research participants that meet inclusion criteria will be asked to provide
informed consent, demographic information and interview dates will be provided.
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Participants will be assigned a study number and information will be maintained in a
linking log.
Instruments. The PI will serve as the research instrument in the proposed
qualitative study (Lincoln and Guba, 1985) and use reflexivity to address bias. A
reflective journal will be used for the PI to distinguish between the PI’s subjectivity and
the observable phenomenon. Research study field notes to capture other dynamics along
with analytic and reflective notes will also be collected.
Data Collection. A basic qualitative design, with an interpretative approach is
needed to identify the experiences of LVAD patients (Green & Thorogood, 2014).
Participants will provide written consent prior to enrollment into the study and before
group or individual interviews. After proving consent, patients will be asked to provide
written contact information for follow up interviews. Self-report demographic data will
be collected via survey (Appendix A). Data responses will be coded and blinded.
Participants will be asked to share their experiences in group or individual
interviews. Semi-structured interviews will be used to address themes and topics of
interest in an information or conversation-style dialogue with the LVAD patients. Semistructured interviews allow the principle investigator (PI) to uncover and explore themes
that might be unexpected but prove to be important in understanding the LVAD patient’s
experience and adjustment (Kvale & Brinkman, 2009). The interviewer will guide the
participants to share perceptions of their adjustment to the LVAD through a series of
open-ended questions (Appendix B). The semi-structured interview guide was developed
based on prominent themes published and gaps identified in the current literature on
living with an LVAD (Sandau et al., 2014; Ottenberg et al., 2014; Overgaard et al., 2012;
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Marcuccilli et al., 2011; Casida et al, 2011; Hallas et al, 2008; Chapman et al, 2007). The
interview guide will be further reviewed for relevance of questions and credibility will be
established by the PI and 2-3 LVAD coordinators, who experts in care of the LVAD
patient through the continuum of care (Polit & Beck, 2017). Triangulation will occur by
interviewing different types of individuals in group and individual interviews to obtain
multiple perspectives (Polit & Beck, 2017). The individual interviews will be conducted
to further explore rich cases that align with the study aim or confounding cases
(Brinkmann & Kvale, 2015). Individual interviews will be selected either from the group
interviews or from interested research participants not able to attend the group interviews.
Interviews will be emergent in design and allow the questions to adapt to further explore
issues that arise from patient comments. (Brinkman & Kvale, 2015). Interviews will be
conducted in English by the study PI using a semi-structured interview guide with grand
tour and mini tour questions.
The group interviews will consist of approximately 5 to 10 patients and emergent
in design and allow the questions to adapt to further explore issues that arise from patient
comments. Patients will be clustered by device implant indication, BTT or DT, to allow
patients, the opportunity to speak openly concerning their experience. The same semistructured interview guide will be used for the BTT and DT interview groups to compare
experiences of the two groups. The emergent design will allow the questions to adapt to
further explore factors that are specific to each group. Field notes/observations will be
taken by the PI during recruitment and interviews to document the inflections, tones, and
nonverbal cues (Kvale & Brinkman, 2009). At the end of the interview dependability will
be established by the interviewer by confirming that the participant’s responses were
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complete and accurate (Polit & Beck, 2017). Patients will be informed that all names
mentioned in the interview will and protected health information will be removed in the
transcription of the interview. Patients may be asked to participate in individual
interviews following group interviews.
Data Management. Audio recordings will be downloaded onto a passwordprotected server at UTH. Every audio file will be identified with a study identification
number and uploaded onto the server. Audio files will be downloaded and shared with
the transcriptionist via a secured shared site. Once the transcription is complete it will be
loaded onto the server, with study identification, and the PI will be notified by email.
The transcript will then be verified for accuracy and authenticity by the PI by listening to
the audio recording and comparing it to the transcript (Polit & Beck, 2017). All
references to names or places will be removed from the transcription. Audio recordings
will be kept on the secure server until all study interview and transcripts are finished. At
completion all recordings will be deleted, and the transcripts will be stored by study
number on the password-protected server.
Despite security measures and the use of study ID numbers, there could be a
breakdown in protecting the identity of interview participants. If a breach in participant
confidentiality were to occur, we will notify the participant and IRB as soon as the
incident was discovered. We would create an action plan to prevent future breaches.
Violations in the conduct of the study will also be reported to the IRB as soon as they are
identified.
The PI will be appropriately trained for handling human subject-related data
(including protected health information (PHI) that may be disclosed by a participant). All
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protected health information (PHI) data collected by the PI or disclosed by a participant
will be de-identified. Study participants will be assigned a study identification (ID)
number in lieu of a participant name.
Data Analysis. Data analysis of interviews, field and analytical notes will begin
as soon data is collected. This will allow for evaluation of the effectiveness of the group
interview techniques and questions for collecting information, and any necessary
adjustments will be made early in the interview process. Data collected will be deidentified. The PI will review and become familiar with the data collected from the first
participants (group interviews, journals, field notes, and artifacts) (Miles, Huberman, &
Saldana, 2014). Transcriptions will be imported into Atlas’s version 8 for Windows
(Scientific Software Development GmbH, 2017) for data coding, analysis, and
management leading to preliminary themes. Codes will be identified and developed
iteratively from the data and a codebook will be developed (Saldana, 2009). Codes will
be established and categorized for themes, constructs, models, etc. (related to the research
questions) by the PI. Supporting quotes will be used to support the data (Miles, et. al,
2014). Transcriptions will be analyzed recursively validating the emerging themes and
patterns. Data will be compared and contrasted to ascertain similarities and differences
between the BTT and DT participants. Lastly, peer debriefing will be done with
dissertation committee members who are familiar with the research approach, to
substantiate the themes, eliminate bias and make the finding resonate with the providers,
thereby establishing trustworthiness (Saldana, 2009). In qualitative research, the PI will
serve as the research instrument (Lincoln and Guba, 1985). Therefore, to further enhance
the rigor of the data, reflexivity will occur by ongoing dialectical analysis, with the PI
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keeping a journal with analytic notes, to avoid bias (Korstjens & Moser, 2018).
Sampling will continue until good depth and repetition or “saturation” of themes is
reached, and little new information emerges (Green & Thorogood, 2004). Analytical
notes will be taken throughout data analysis.
Potential Problems and Alternative Strategies. Despite adequate population
size, recruitment of patients can potentially be a challenge. Therefore, a contingency plan
is in place. The Heart Exchange, a LVAD and heart transplant support group, is well
established and eager for programs that may assist in increasing the understanding of
LVAD patient illness perspective. Therefore, if recruitment lags, there are plans in place
to work with Heart Exchange Support Group to supplement recruitment. Faculty advisors
have experience recruiting from patient and family support groups for qualitative
research interviews. They will provide guidance and recommendations for recruitment, as
needed.
Because the PI works at BSLMC as an Advanced Practice Registered Nurse
(APRN), she may have encountered some of the study participants in a clinician role.
The PI will emphasize the research role and verbalize that no responses will impact
clinical care provided. The PI will also attempt to minimize clinical contact with research
participants. To maintain the PI role, group interviews will be conducted at UTH Center
for Nursing Research if possible and patients from both MH and BSLMC will
interviewed together. The PI will also attempt to recruit and include patients in whom
there is limited or no previous clinical provider encounter. Additionally, the PI will
consult faculty advisors if any conflicts arise.
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Risks to Human Subjects and Ethics
Prior to study initiation, the study protocol will be reviewed and approved by the
UTHealth Committee for the Protection of Human Subjects (CPHS) and Baylor St.
Luke’s Medical Center and Memorial Hermann Institutional Review Boards (IRB), and if
deemed necessary, additional safeguards and monitoring will be added to the protocol.
All research team members will receive and maintain the UTHealth Protection of Human
Subjects training.
The potential risks involve discomforts related to discussing symptoms of end
stage HF and either waiting for or ineligible for heart transplantation. Therefore, patients
will be clustered by implant indication to create a more homologous group and increase
the patients’ ability to share openly. Additional potential risks associated with the study
are loss of confidentiality. Mechanisms are in place to minimize these risks. All
participating patients prior to the study onset will provide verbal informed consent
approved by the UTHealth CPHS and IRB. All patients will be given the opportunity to
refuse participation in the study and will be told that non-participation will not affect
services (e.g., MH LVAD/HF Clinic service, BLSMC LVAD/HF Clinic, United Network
for Organ Sharing (UNOS), etc.). To protect the confidentiality of the patients, all hardcopy records will be filed in locked cabinets and electronic records password protected
computer systems within locked offices within the UTHealth School of Nursing for use
by authorized personnel only. Hardcopy files (e.g., informed consents) will be saved
securely during and after study completion until proper data destroying, if applicable
following established UTHealth guidelines. All necessary firewall and password
protections will be implemented to ensure confidentiality of data. No LVAD patient data

19

will be shared with their informal caregiver and vice versa. All patients’ records will be
given a unique study identification number. No PHI will be used in reports. No PHI will
be kept on the secured computer where the study data is collected, managed or stored.
The PI will regularly consult with faculty advisors concerning confidentiality,
data management and participant safety concerns. Although it is anticipated that any
negative thoughts or feelings will be manageable, appropriate measures will be taken to
ensure the safety of the patients. During the interviews if any of the patients become
upset, they will be offered the option of withdrawing from the study without penalty or
continuing at another time. Patients will also be informed that they may choose not to
answer any item(s). In the event of any emotional distress, the PI and research staff will
remain with the participant until the participant is no longer distressed or appropriate
clinical care has been obtained.
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Left Ventricular Assist Devices (LVADs) are mechanical pumps that assist
advanced heart failure (AHF) patients by unloading the left ventricle and increasing
cardiovascular circulation throughout the body. LVADs are the most widely used heart
pump. There are two primary indications for LVAD therapy (e.g., bridge to transplant
[BTT] and destination therapy [DT]). Both groups experience similar self-care
requirements with the LVAD; however, the length of time supported on therapy for the
two groups can vary greatly. At present, LVAD training and patient education are the
same for both groups. To date, no studies have explored if patients adjust differently to
the devices based on the implant indication. This information is essential to optimize
patient experience and facilitate the LVAD patient’s adjustment to living with the
therapy. Furthermore, LVAD adjustment has the potential to impact patient morbidity
and mortality directly.
LVADs are increasing as a therapy option for patients experiencing AHF. Over
30,000 AHF patients were implanted globally in the past decade, and approximately
2,000 patients are implanted with LVADs annually in the United States (U.S.) (K.L et al.,
2014). LVADs have demonstrated the ability to improve the quality of life and improve
the mortality of AHF patients (Grady et al., 2014). The internal pump is implanted in the
left ventricle and attaches to the aorta to increase the cardiac output. It connects to
external components through a set of wires that exit the abdomen known as the driveline,
which connects to an electronic microprocessor, the "controller," that operates the device.
LVAD patients must always rely on external batteries or an AC power source to support
the device.
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Unlike other medical therapies with only internal components, LVAD patients
have external equipment that the LVAD recipient and caregiver must learn to manage.
LVAD patients cannot participate in activities that place the patient, driveline, and
equipment at risk of getting wet or submerged in water. Due to these factors, the external
LVAD components significantly impact the patients’ activities of daily living (e.g.,
driving, swimming, tub bathing, or boating) and create a complex adjustment process. In
addition to modifications necessary for ADLs, LVAD recipients must learn to change
power sources, ensure access to an adequate power supply, perform regular sterile
dressing changes to the driveline exit site, and respond to hazardous and critical LVAD
alarms.
Review of Qualitative Literature
To date, a limited number of qualitative studies have explored LVAD adaptation
in patients living with a second or third generation continuous-flow LVAD. One study
described the importance of LVAD patients being able to be independent in most ADLs
living or activities that the LVAD recipient valued as important (Sandau et al., 2014).
Multiple studies have reported participants’ gratitude for the LVAD. The gratitude was
reported and expressed as the opportunity to 'feel alive again' or gaining a 'new lease on
life', previously thought as impossible while living with AHF (Casida et al., 2011;
Ottenberg et al., 2014; Overgaard et al., 2012). In contrast, some participants verbalized
ambivalence towards the LVAD (Overgaard et al., 2012).
Multiple studies reported the importance of LVAD recipients to regain a sense of
normalcy (Casida et al., 2011; Sandau et al., 2014), which included being able to
participate in activities that LVAD recipients valued as essential. Communication was
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valued as extremely important in the adjustment process and minimized the sense of
isolation and loneliness of living with the device (Modica et al., 2015; Ottenberg et al.,
2014). Vocational adjustments were important component of regaining normalcy. A
Danish study identified younger LVAD recipients struggled more returning to
employment than older recipients that may be more established in careers before the
LVAD or retired (Overgaard et al., 2012). This study emphasized the importance of
evaluating physical, psychological, social, and vocational adjustments of LVAD
recipients based on developmental age (Overgaard et al., 2012).
A study focused on DT LVAD recipients, emphasized preparedness planning
before receiving the LVAD, optimizing support networks, systemic limitations of living
with an emerging therapy (Ottenberg et al., 2014). In another study exploring BT LVAD
recipients' experience, the emphasis was placed on a sense of freedom from AHF only to
be dependent on the LVAD. Waiting on a heart transplant only magnified the desire for
freedom (Modica et al., 2015). During the waiting period for a heart transplant, the
concept of time also took on a new meaning (Ottenberg et al., 2014). LVAD recipients
viewed the LVAD as a prosthetic organ or 'experimental,' and the reliability of the device
questioned over time (Modica et al., 2015). A study conducted in the United Kingdom,
reported the LVAD created a liminal identity, served as a temporal disruption to one’s
life while waiting on a transplant, and the devices itself served as a liminal object
supporting the recipient only until a new heart was available (Standing et al., 2017).
Complexities of Living with an LVAD
The external equipment presents unique challenges and complexities of living
with an LVAD. Before hospital discharge, LVAD recipients must learn essential skills
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regarding LVAD maintenance (e.g., e.g., system maintenance, securing adequate power,
driveline immobilization, and driveline dressing changes) (Kato et al., 2014) and
managing emergency alarms. Once patients return home, they must learn to incorporate
these skills into their home environment and activities of daily living (e.g., hygiene,
medication adherence, physical activity, nutrition, sleep, and rest) (Kato et al., 2014).
One study identified that adjustment and incorporating LVAD self-care to the
LVAD is a process that occurs in two phases: (1) early home adaptation and (2) late
home adaptation (Casida et al., 2011). During the early home adaptation phase, patients
often notice an increase in energy and physical ability. Despite this increase, LVAD
patients remain heavily dependent upon a caregiver for assistance performing activities
related to hygiene, medication adherence, and transportation, among other self-care
activities, which can be a source of frustration (Casida et al., 2011). Often changes to the
home environment (e.g., electrical work to support the device, home generators) are
required to support the LVAD optimally.
Additional studies identified the following inconveniences during LVAD
adjustment: frequent travel for clinical appointments and laboratory services,
psychological stressors (e.g., alterations in body image and surgical scares) (Chapman et
al., 2007; Linda Marcuccilli et al., 2013), and modifying equipment during physical
activity (e.g., exercise and sexual intimacy) (Alonso et al., 2018; Hallas et al., 2009;
Marcuccilli et al., 2011).
In other studies, patients discussed a change in their sense of normalcy including
the ability to improve in the management of the LVAD and incorporate daily activities
such as cooking, sleeping, and hygiene (Casida et al., 2011; Chapman et al., 2007; Hallas
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et al., 2009; Overgaard et al., 2012). In the early home adaptation phase, the LVAD
patient often describes mixed emotions ranging from fear of LVAD complications to
increasing confidence in self-care (Casida et al., 2011; Chapman et al., 2007; Overgaard
et al., 2012). During late adaptation, LVAD patients also described difficulties returning
to work and resuming previous roles. Patients discussed the difficulty of returning to
work and resuming previous roles (Casida et al., 2011; Chapman et al., 2007; L.
Marcuccilli & Casida, 2011; Overgaard et al., 2012; Sandau et al., 2014). Most
importantly, LVAD patients described the importance of returning to normalcy, including
the desire to appear normal in public (Casida et al., 2011; Ottenberg et al., 2014; Sandau
et al., 2014)
LVAD Implant Indication
The two most commonly used device implant strategies include bridge to
transplant (BTT) and destination therapy (DT). BTT is an implant indication used for
patients actively listed for heart transplantation, utilizing an LVAD to prevent death or
progressive end-organ dysfunction while awaiting transplant (Shudo et al., 2017). DT is
an implant indication for patients who are not eligible for heart transplantation due to
relative or absolute contraindication (e.g., body mass index, age, substance abuse, or
malignancies) that will be supported by the LVAD for the remainder of life (Shudo et al.,
2017). Despite the clinical implant indication at the time of LVAD surgery based on the
recipients' ability to meet heart transplant criteria, implant indication can also evolve as
the patient's conditions regarding transplant eligibility change over time (e.g., abstinence
from illicit drugs, cessation of tobacco use, or weight loss) (Shudo et al., 2017).
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The self-care requirements are the same for BTT and DT patients. The main
differences in the two groups are the anticipated length of time on LVAD support and the
anticipation of a heart transplant. The length of time BTT and DT patients live with an
LVAD can vary dramatically. LVAD BTT patients may receive a heart transplant as
early as six months after LVAD implant or may wait a couple of years supported on the
device. Twenty to thirty percent of BTT patients receive a heart transplant by one year
after device implantation (Kirklin et al., 2015). LVAD therapy is often most beneficial to
patients that have extended time on the transplant waiting list (e.g., ABT blood type,
large body habitus, or the presence of anti-HLA antibodies) (Shudo et al., 2017).
Due to the advancements in technology and improvements in patient care, the use
of LVADs for patients has increased dramatically for patients not meeting transplant
eligibility. In the 2006-2007 INTERMACS registry, 14.7% of patients received an LVAD
as DT, which quickly increased to 46% by 2011-2014, making DT the prevailing strategy
among all LVAD implantations (Kirklin et al., 2014, 2015). Patients can live as DT with
a single device for greater than ten years and longer if supported by consecutive devices.
DT LVADs have the potential to not only reduce the burden of limited organ supply but
eventually may challenge heart transplantation as the standard of care for AHF patients
(Kirklin et al., 2012).
Purpose
There is limited literature exploring the LVAD patient experience and adjustment
to the device. Additionally, no known studies have explored if there is variation in how
patients construct the impact on daily life and self-care or the LVAD patient experience
based on implant indication. Therefore, the specific aims of this study were to explore
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LVAD patient experience, describe how patients construct the impact of the LVAD on
daily life and self-care, and compare the findings between BTT and DT patients. The
following research questions were posed: (1) How do patients living with an LVAD
perceive the comprehensive experience? (2) What are the perceived issues and challenges
regarding LVAD adjustment? and (3) Do LVAD patients adjust differently according to
the self-reported treatment trajectory (BTT or DT)? It is imperative to understand how
BTT and DT LVAD recipients construct the patient experience in order to provide
patient-centric education for each group and promote optimal adjustment.
Methods
The study used a general qualitative methodology with an interpretative approach
to explore the perspectives of LVAD patients and achieve the aims of this research
(Crabtree & Miller, 2009).
Setting
The setting for this study was the Texas Medical Center (TMC) located in
southeastern Texas. The TMC is the largest life sciences location in the world. It is home
to 54 institutions, five of which implant LVADs. Pioneering heart surgeons from the
TMC have profoundly contributed to the development and advancement of the LVADs.
Participant recruitment and sampling occurred in the outpatient clinic of two LVAD
programs within the TMC, Baylor St. Luke's Medical Center (BSLMC), and Memorial
Herman-Texas Medical Center (MH-TMC). The two programs collectively implant
approximately 150 LVADs annually and manage routine care for over 300 patients.
The University of Texas Health Science Center at Houston, Cizik School of
Nursing (UTHSC-CSON) served as the preferred location for both group and individual
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interviews due to clinical neutrality. If participants were unable to access the CSON or
had scheduling conflicts, interviews occurred at the LVAD clinics coinciding with a
routine clinic visit.
Participants and Sampling
Participants were men and women currently implanted with an LVAD. The
inclusion criteria for participants with LVADs were (a) adult participants (age > 18
years), (b) able to speak English, (c) currently living with a HeartMate II, HeartMate 3, or
HeartWare device, and (d) greater than one-month post LVAD implantation. Sampling
began with a purposeful sampling of LVAD outpatients from the two LVAD centers
(Polit & Beck, 2017). As recruitment began to become saturated among a specific
typology (i.e., BTT), the researcher used theoretical sampling to explore further the
differences and similarities between the two typologies in question (BTT and DT) (Polit
& Beck, 2017). To achieve variation within the sample, extreme or deviant case sampling
and typical case sampling were also utilized (e.g., participants with challenging
postoperative courses, device malfunctions, and replacements) (Green & Thorogood,
2004; Polit & Beck, 2017). Participant sampling and recruitment ceased once data
saturation was reached.
Data Collection
Data was collected using open-ended group, and one-on-one interviews using a
semi-structured interview guide (Table 1). The guide was developed based on the
conceptual framework, Callista Roy's Adaptation Theory (Roy, 2009), a grand theory that
focuses on the individuals’ ability to adapt with the internal and external environment.
Faculty with expertise in qualitative research also provided input on the interview guide.
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Key questions included (a) How did you first learn about an LVAD? (b) How the LVAD
impacted you physically. Psychologically? (c) Tell me about how the LVAD has
impacted your ADLs. (d) How has the LVAD impacted your self-concept? (e) How has
the LVAD has impacted your personal and professional roles (e.g., parent, spouse,
employee, student)? As data analysis and collection continued, interview questions
evolved in order to explore further emerging themes or concepts related to the adaptation
process. Interviews were audio-recorded with participant written consent, and field notes
were collected. The recordings were transcribed verbatim by a professional
transcriptionist and verified for accuracy. All data were de-identified in order to protect
confidentiality.
All LVAD participants completed a demographic survey. Demographic
characteristics collected included self-reported age, race, gender, marital status,
educational level, employment status, household income, LVAD device type, the reason
for LVAD (e.g., BTT or DT), and length of time with LVAD.
Procedures
The UTHSC Institutional Review Board approved the study before data collection
initiated. Study flyers were placed in outpatient clinic rooms or distributed by LVAD
clinical providers at both AHF clinics. Onsite recruiting and screening for eligibility
criteria also occurred at both clinics. If individuals met inclusion criteria and expressed
interest in participating in the study, written informed consent was obtained and selfreported demographic data were collected. Participants then scheduled an appointment
for an interview. Other participants who learned of the study from a study flyer contacted
the researcher by phone or email and scheduled an appointment for an interview at the
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CSON or one of the AHF clinics. These participants provided written informed consent
and completed the demographic survey before the interview initiated.
Interviews were conducted in a quiet, comfortable location within the UTHSCCSON or LVAD clinics. Participants from both LVAD centers were scheduled for group
interviews according to self-reported LVAD indication (e.g., BTT or DT) in order to
attain homogeneity and allow participants to speak openly concerning their experiences.
Faculty from the UTHSC-CSON with expertise in qualitative research observed three of
the interviews and provided feedback to ensure consistent data collection techniques.
After the interviews, participants received a small honorarium ($10 gift card) and a
parking voucher.
Data Analysis
Data analysis began shortly after data collection was initiated and continued
throughout the data collection process. All audio recorded interviews were transcribed
verbatim by a professional transcriptionist. Transcripts were proofread in order to
develop a comprehensive understanding of the data and validate the transcription. The
research team used peer debriefing and discussion to ensure credibility and dependability.
Field notes, reflexive journaling, and an audit trail were collected to ensure transferability
and confirmability (Lincoln & Guba, 1985).
Participants were assigned a study identifier and de-identified data (e.g.,
transcripts, field notes) were obtained. Hard-copy data was secured and stored behind a
double lock at the UTHSC-CSON. Electronic data was stored within a secure online
database (REDCap) behind UTHSC-CSON encrypted drive and firewalls. Transcripts
were imported into ATLAS.ti version 8, a data management software program for
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qualitative research (Scientific Software Development GmbH, 2017) to iteratively
identify codes and a codebook developed. Themes, constructs, and a model were
developed with recursive analysis and peer debriefing. Sampling continued until a good
depth and repetition of themes were reached and little new information emerged.
Findings
Sample Characteristics
The sample consisted of 13 men and seven women (Tables 2 and 3). Eight
identified as black, ten white, and two as more than one race (black/white and
white/another race not indicated). The participants had been supported by LVAD therapy
for a mean of 35.6 months and ranged from three months to 146 months. Three of the
participants had experienced LVAD complications requiring device replacement. Two
participants had two consecutive pumps, and one of the participants required two pump
exchanges resulting in a total of three LVAD devices over an 11-year time frame (two
HeartMate II devices and one HeartWare device).
At the time of data collection, HeartMate II devices supported five of the
participants, HeartWare devices supported 12 participants, and HeartMate 3 devices
supported three participants. Fourteen participants self-identified as bridge to transplant
(BTT) (70%) LVAD recipients and six identified as destination therapy (30%) LVAD
recipients. Of the participants that reported BTT, eight of the participants self-reported
being listed for a heart transplant and six of the participants self-reported not listed for a
heart transplant (Table 3). Most of the participants were married (55%), had some
college, but no degree (40%), were retired (45%), and reported an income of less than
$20,000 annually (50%).
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Living with the LVAD: A Second Chance at Life
In order to describe how LVAD patients construct the impact of the LVAD on
daily life and the holistic self, a linear and sequential model was developed (Figure 1).
The model depicts the three separate phases representing the LVAD patient experience,
(1) illness perception, (2) LVAD adjustment, and (3) health aspirations. Each phase
directly influences the phase(s) that follow. Before receiving the LVAD, participants
recalled aspects of living with AHF and what it was like to first learn about LVAD
therapy. The perception participants of the illness process before LVAD directly impacts
how one perceives LVAD adjustment.
Following the LVAD implant, participants described six components that
impacted LVAD adjustment and the holistic self. The six components include (1)
physical ability, (2) caregiver dependence, (3) self-care, (4) roles, (5) LVAD public
perception, and (6) connection. The factors that participants discussed as the most
relevant following LVAD implantation included one's physical ability and caregiver
dependence. As time progressed and recipients progressed through the LVAD adjustment
process, self-care and roles became important, followed by LVAD public perception and
connection.
The LVAD recipient's perceived LVAD trajectory (BTT or DT) influenced the
LVAD adaption process. It is this perception that influences all aspects of LVAD
adjustment but does not differ based on implant indication. The holistic person, as well as
health aspirations, were most heavily influenced by the perceived treatment trajectories
and differed based on perceived BTT treatment trajectory or perceived DT treatment
trajectory. The LVAD recipients that reported they were BTT expressed future
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motivations for heart transplantation. Those that reported DT described future aspirations
of LVAD device longevity (e.g., support on LVAD therapy for more than ten years).
Overall, both BTT and DT participants reported various inconveniences associated with
living with an LVAD; however, they also expressed the LVAD was life-sustaining. Most
participants expressed heartfelt gratitude for a second chance or "New Lease on Life."
Illness Perception
Illness perception includes descriptions of the AHF disease process and symptoms
before receiving the LVAD. Additional key findings worth noting included: experiences
regarding AHF care from community providers (e.g., local primary care providers or
cardiologists not specializing in AHF treatment options [LVAD or heart transplant]),
initial introduction to an LVAD, having a limited choice regarding the acceptance of the
LVAD, and the surgical recovery following the LVAD implant. Table 4 provides
participant exemplars.
Advanced Heart Failure (AHF).
Almost all participants described significant AHF symptoms (e.g., shortness of
breath, edema, orthopnea, dyspnea on exertion, and limited mobility). Participants
emphasized being able to walk only a short distance without having to stop and sit down.
The symptoms also limited the participants' ability to perform ADLs. Participants'
symptom burden with AHF was directly influential on the participant's expectations postsurgical implant of the LVAD.
Community Care.
Many participants noted positive experiences regarding initial AHF care by
community providers and expressed gratitude for being referred to an LVAD center.
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Others noted frustration in delayed referrals for AHF treatment or "not being heard" by
providers in the community, requiring the participant to seek advanced therapies
independently. One female participant reported instructions from her health care provider
to lose weight and that would resolve all her AHF symptoms would resolve. Her
concerns were ignored despite her persistence that something was wrong aside from her
increased weight. Participants also reported participants also discussed a lack of
community awareness of LVADs. Many of the participants had very limited or no prior
knowledge of LVAD therapy. Participants that were less familiar with the LVAD before
receiving the device experienced increased challenges in the LVAD adjustment phase. In
contrast, one participant that received the LVAD after her bother received a device. She
described a seamless transition through the phases of LVAD adjustment after witnessing
her brother's experience.
Introduction to an LVAD.
All participants discussed thorough education about the LVAD by clinical
providers (e.g., physicians, LVAD coordinators); however, the time from initial
introduction to device implant varied significantly among participants. A couple of the
participants noted being supported by medical therapy for approximately one to three
years before receiving the LVAD. Other participants described being admitted to the
hospital for the LVAD either immediately or within days after the initial AHF clinic visit.
The participants with extended time between first introduction and LVAD implant
reported researching LVADs through social media (e.g., Facebook groups, online chats,
YouTube), appeared to more readily adjust than those that had a short period between
introduction to the LVAD and device implant.
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Limited Choice.
During AHF symptoms, participants expressed having a limited choice when
having to decide on an LVAD; however, participants recognized that death was a choice.
Several participants verbalized being comfortable with the thought of death, however
opting to give the LVAD a try. A female respondent discussed being very reluctant to
receiving the LVAD; however, after discussing in-depth with her cardiologist and
thinking on aspects of her life that she valued (e.g., family, grandchildren), she opted to
proceed with an LVAD. Male and female participants alike reported being in the hospital
and acknowledging they would die or discharge on hospice if they chose not to receive
the LVAD. Patients that self-reported DT often felt they had a limited choice regarding
treatment options (e.g., LVAD vs. heart transplant). Some participants adjusted well,
regardless of having a limited choice in treatment options. Others, most commonly DT
participants, did not adjust optimally due to limited choice.
Cardiac Surgery and Recovery.
Several participants described anxiety related to anticipation of a sternotomy,
cardiothoracic surgery, waking up with an endotracheal tube inserted, and being
mechanically ventilated. Multiple participants described anxiety and stress when
recounting aspects of the cardiac surgical recovery (e.g., intubation and ICU delirium).
Some respondents described a lack of pre-surgical knowledge of intubation. Additional
respondents expressed fear and great distress recalling waking up with the breathing tube
inserted and not being able to communicate effectively. Multiple participants vividly
recalled the trauma of intubation and surgical recovery despite how long the recipient had
been living with an LVAD.
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LVAD Adjustment
LVAD adjustment refers to an individual’s ability to adapt or incorporate the
LVAD into daily life. Both BTT and DT participants described a similar LVAD
adjustment process. When describing adjustment, participants described six components
of LVAD adjustment that progress from left to right in order of importance (e.g., moving
from LVAD implant towards the Future): (1) physical ability, (2) caregiver dependence,
(3) self-care, (4) roles, (5) LVAD public perception, and (6) connection.
Overall, participants all discussed successfully achieving LVAD adjustment.
Participants noted challenges related to adjustment, and the time required for getting back
to normal varied among participants from a couple of weeks to approximately two years.
Components of LVAD Adjustment.
This study identified six specific components of LVAD adjustment, as previously
described. Each component is independent of the other components, yet directly
influences the holistic self. Components can influence one another through the
transformation of the holistic self. Table five presents participant exemplars regarding the
specific components of LVAD adjustment.
Physical Ability.
Physical ability refers to one's ability to perform a physical act. Many participants
described a noticeable difference in their physical ability very quickly after the LVAD,
while others noted a gradual improvement over many months. Because of the dramatic
physical impairments before the LVAD, often, physical improvements were one of the
first items that participants expressed, as demonstrated in the model (Figure 1). Multiple
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respondents described having increased energy. A few participants noted having this
increase in energy as early as a couple of days to weeks post-operatively.
In contrast, others reported it taking one to two years to return to what the
recipient considered 100%. Others discussed being able to do significantly more activities
(e.g., cooking, washing the dog, mowing the grass, planting a garden) than before
receiving the LVAD. One participant reported a very lengthy post-operative recovery
lasting over ten months. This decrease in acute physical ability post-LVAD negatively
impacted adjustment. The participant noted that while he was still improving in his
strength, he still noted remarkable differences from the participants in the group
interview.
Caregiver Dependence.
Despite improvements in physical ability, participants initially required assistance
from caregivers. Caregivers varied, one participant described his wife, a nurse, being his
primary care provider due to her healthcare background. Others noted parents, spouses,
or multiple family members collectively taking on the caregiver role. As time progressed
with the LVAD, many participants described gaining more independence and requiring
little help from a caregiver, and some eventually achieved independence. One participant
reported living completely alone and successfully managing her LVAD for over three
years with a limited support system.
Self-Care.
Self-care refers to the behaviors performed in order to improve well-being,
preserve health, maintain physical ability, and emotional stability (Riegel et al., 2012).
One of the largest aspects of LVAD self-care is self-care maintenance (Kato et al., 2014).
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Multiple participants reported an acute awareness of the driveline and battery
cables. This acute awareness of the external equipment often became a social barrier as
participants described a fear of having the battery cables or driveline disconnected in
large crowds. Participants also described difficulty managing the equipment in stadium
seating for professional sporting events (e.g., baseball) or entertainment venues (e.g.,
symphony, concerts).
Aside from the external LVAD equipment, the device weight was the next most
impactful aspect of device management. One participant who received his device soon
after being introduced to the device described being very surprised about the weight of
the external equipment. Many participants noted the device weight limited exercise
tolerance and limited ADLs.
Due to the inability to get the LVAD wet, LVAD recipients had to take
precautions to ensure the driveline exit site and external equipment stayed dry when
performing hygiene. Securing the driveline exit site and equipment could take up to 30
minutes to an hour and required assistance from a caregiver. Due to the complex process
of taking a shower, many participants described taking "hospital type" sponge baths.
Universally, the women reported significant inconveniences with clothing
selection. Women were also overall more concerned with the bag and accessories used to
manage the external LVAD equipment. One male participant, currently employed as a
law enforcement detective, expressed concerns regarding clothing and device wearables.
He reported that despite modifications, most clothing made it extremely complicated for
him to manage the LVAD and law enforcement equipment. He noted that when trying a
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tactical shirt used by many LVAD recipients, the controller overheated while performing
routine job duties due to prolonged exposure to the heat.
Participants described inconveniences related to sleep and the management of the
external LVAD equipment. The most common inconvenience reported was positioning
the LVAD in order to be comfortable for sleep. One participant expressed anxiety and
fear of the device controller falling off the bed in the middle of the night and pulling the
driveline out of his chest. Another participant reported sleeping on batteries, despite
medical recommendations to sleep on AC power, due to the necessity to get up and
urinate throughout the night.
Participants described various practices and clinical recommendations regarding
driving. Many participants described the return to driving and even completing some
long-distance trips by care, while others noted returning to driving but only in a limited
area. Others reported not returning to driving at all due to medical recommendations. One
participant highlighted that with the LVAD, the lap belt now sits appropriately across his
upper thighs rather than incorrectly across the abdomen.
Participants noted complications regarding recreational and leisure activities. Due
to the inability to get the LVAD equipment wet, almost all participants reported
inconveniences and frustrations with not being able to participate in water activities.
Other participants reported inconveniences and frustrations regarding travel. One female
reported feeling uncomfortable and embarrassed about going through airport security.
Other participants report abstaining from or limiting travel due to being temporarily
inactivated from the transplant waiting list while greater than four hours away from the
transplant center.
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Roles.
Roles include the duties that someone has or is expected to have (“Role definition
in the Cambridge English Dictionary,” n.d.). Participants report changing roles that often
started due to AHF. Participants reported decreased ability to participate in family
activities or perform ADLs around the house. Often these roles and ability to contributed
to one’s family improved after the LVAD. A woman described the inconveniences
regarding the LVAD equipment and her interactions as a grandmother. At the same time,
two gentlemen discuss the frustration of not being able to care for grandchildren as
previously before the LVAD.
Several participants reported the loss of employment and having to go on
disability or retire early, while others discussed how the LVAD was preventing a return
to employment. In contrast, participants that reported higher education were often able to
return to employment. These participants often had jobs that did not require heavy lifting,
pose infection risks, and flexible hours to accommodate clinic appointments.
LVAD Public Perception.
LVAD public perception refers to how one perceives people in general, or people
in a country or community, think about the LVAD or the impression they have of the
device. The LVAD bag and accessories were also significant for how women were
publicly perceived and how the weight was physically supported. One woman selected to
carry her LVAD with the controller and batteries strapped around her chest across her
sternum. The unique positioning of her LVAD equipment served as a function to help
support the weight of the device despite outward appearance. Due to the positioning of
her equipment, the participants described situations in which security perceived the
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LVAD as a threat (e.g., bomb). While some participants described a disregard to the
visibility of the external LVAD equipment and public perception, others reported concern
for others perceiving the LVAD was of value and the possibility of attempted theft.
Public misperception was especially true for participants that carried the LVAD, where it
was outwardly visible and used public transit.
Connection.
Connection is defined as "The energy that exists between people when they feel
seen, heard, and valued; where they can give and receive without judgment; and when
they derive sustenance and strength from the relationship" (Brown, 2012). Participants
expressed a connection with clinical providers when they felt seen, heard, and valued.
When waiting for an LVAD, participants often reported connecting to LVAD patients
and gaining insight and strength to pursue and adapt to the LVAD. Once implanted with
the LVAD, participants often derived sustenance from friendships and activities with
other LVAD recipients. It was in these relationships that participants expressed the ability
to share without being judged. Lastly, participants valued connecting with AHF patients
awaiting an LVAD or people in the community that expressed interest in learning more
about the LVAD.
Holistic Person.
The LVAD participant as a holistic person involves being aware of the entire
being and understanding all the components that contribute. All the identified and
described areas of LVAD adjustment identified in Figure 1 contribute to the holistic
person. One of the predominant topics of describing oneself was the desire for normalcy
after receiving an LVAD. Respondents described “normal” as being able to achieve
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specific tasks (e.g., return to golf, grocery shopping, returning to work). Participants also
described how the LVAD prevented specific normal activities (e.g., driving, water
activities).
Participant Perceived LVAD Trajectory.
Within the theme LVAD Adjustment, two trajectories emerged: Perceived BTT
LVAD Trajectory and Perceived DT LVAD Trajectory. The concepts were overarching
influences on the holistic person and the six components of adaptation depicted in Figure
1. However, the trajectory was perceived, either BTT or DT demonstrated the most
significant influence on the holistic person and health aspirations.
Participants that self-reported BTT grappled their holistic self. Internal issues
such as the statistical odds of receiving a heart transplant, perceived disabilities, the
realization that someone must die in order for the LVAD recipient to receive a heart
transplant, equity regarding organs, beliefs regarding artificial life support, and
spirituality regarding life and death.
The holistic self of participants that did not meet transplant criteria, destination
therapy, struggled with inadequacies regarding ineligibility for a heart transplant (e.g.,
age, illicit substance or tobacco use, or BMI). One DT participant reported confidence in
her decision, "it was my choice," to proceed with the LVAD for the duration of her life.
Participants that perceived they were BTT, whether currently on the transplant list
or not, discussed factors that motivated them to the goal of a heart transplant, while those
that perceived themselves as DT discussed the desire for device longevity and outliving
current technological trends.
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Health Aspirations
Health Aspirations referred to hopes or ambitions of achieving something specific
to their health. Overall, participants' initial health aspirations focused on the tasks
necessary for survival. Many described acute awareness that without the LVAD, death
was imminent.
Motivation for Heart Transplant.
BTT and DT participants' responses differed regarding health aspirations of living
with AHF treatment (i.e., LVAD). BTT participants listed for heart transplant reported
specific reasons for the pursuit of a heart transplant. One individual expressed that he was
a public speaker and felt that his story would be complete with the transplant. Another
reported that he could live for the remainder of his life with the LVAD; however, he was
on dialysis, which significantly decreased the quality of his life. In order to receive a
kidney transplant, he would also need a heart transplant.
LVAD participants that were not on the transplant list expressed aspirations of
achieving heart transplant criteria (i.e., weight loss, achieving a period tobacco-free) and
the intent to continue to the transplant list. One participant reported her struggles to lose
weight, ultimately delaying her from transplant listing, and attributed such difficulties to
the possibility that she was not entirely comfortable with someone dying for her to
receive a heart transplant
Device Longevity.
Due to the relatively new advancements in LVAD technology, the comprehensive
longevity of the LVAD is unknown. Currently, some patients have been supported by a
single LVAD for over a decade. Additionally, if LVAD recipients experience
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complications with one pump, the pump can be exchanged for a new device. LVAD
replacement is often a relatively uncomplicated surgery that generally yields favorable
results. DT participants expressed health aspirations of extended life on the LVAD (i.e.,
greater than ten years) or technologic advancements that could replace the current LVAD
(i.e., future generation LVAD pumps). One participant discussed how his heart was
overall in great condition; therefore, the pump should last a very long time (e.g., greater
than ten years).
Living with an LVAD is Inconvenient but Life-Sustaining
The single overarching theme of the study reported by participants; living with an
LVAD is inconvenient, but life-sustaining. Participants constructed the LVAD patient
experience in three phases: (1) illness perception, (2) LVAD adjustment, and (3) and
health aspirations. Participants described the LVAD adaptation process in greater detail
with emphasis on six components: (1) physical ability, (2) caregiver dependence, (3) selfcare, (4) roles, (5) LVAD public perception, and (6) connection. Each of these
independent components of LVAD adaptation impacts the holistic person and vice versa.
The independent components do have the potential to influence other components as it
influences and changes the holistic person.
Both groups of participants (BTT and DT) constructed similar phases of how the
LVAD impacted daily life and self-care (e.g., illness perception, LVAD adjustment,
health aspirations). Perceived LVAD trajectory begins at the time of LVAD implant and
influences LVAD adaptation and the respondents' health aspirations. Participants who
identified as BTT expressed individual and specific motivations for pursuing a heart
transplant, where participants who reported they would have the LVAD for the rest of
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their life (DT) reported hope and desire to live greater than ten years with the LVAD
technology. The overarching theme acknowledged that living with an LVAD certainly
has its challenges; however, it allows for the patients to experience a second chance at
life.
Discussion
Living with the LVAD: A Second Chance at Life
Understanding the process in which LVAD recipients construct the overall patient
experience is essential to optimizing LVAD adjustment resulting in improved patient
outcomes. The model (Figure 1) depicts the three phases described by participants in this
study.
Previous studies have identified components of LVAD self-care (Casida et al.,
2011; Chapman et al., 2007; Kato et al., 2014; Overgaard et al., 2012); however, this
study notes the emphasis on individuals striving to achieve independence in caring for the
LVAD. For example, one participant reported living alone with the LVAD for over three
years. The study also identified inconsistencies in patient-perceived LVAD self-care
instructions or requirements (e.g., dressing change frequency and supply process, driving
allowances, and dietary recommendations). The researcher observed these inconsistencies
among participants within the same LVAD center in addition to the two separate LVAD
centers.
Previous research highlighted the phases in which LVAD self-care occurred: (1)
early home adaptation and (2) late home adaptation (Casida et al., 2011) and noted the
adjustment to self-care activities could be a source of frustration (Casida et al., 2011).
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This study expanded on the components of LVAD adjustment and highlighted the
importance of roles, LVAD public perception, and connection in the adaptation process.
Previous studies highlighted the desire for normalcy. In these studies, participants
described normalcy as incorporating the LVAD into ADLs the recipient valued or
looking normal in public. (Alonso et al., 2018; Casida et al., 2011; Chapman et al., 2007;
Hallas et al., 2009; Marcuccilli et al., 2013; Ottenberg et al., 2014; Overgaard et al.,
2012; Sandau et al., 2014 ). In this study, participants emphasized specific activities by
which participants measured normalcy (e.g., golf, grocery shopping) rather than public
appearance.
Clinical Impact Trajectory vs. Patient Perceived Trajectory
All LVAD recipients are assigned a clinical implant indication based upon the
recipient's ability to meet transplant criteria. Recipients must often wait a minimum
period of six months post LVAD implant in order to allow for surgical recovery before
heart transplant listing. Additional factors (e.g., BMI, substance abuse, health care
compliance, limited social support) may delay an LVAD recipient's activation on the
heart transplant list. The study identified a possible disconnect regarding clinical the
clinical implant trajectory and the self-reported LVAD trajectory and self-reported heart
transplant listing status. Fourteen participants self-identified as BTT candidates; however,
only nine self-reported actively on the list for a heart transplant. This discrepancy
presents the need for further research as to why participants would perceive they are BTT
candidates despite not being active on the heart transplant list.

66

Future Implications
Clinical Practice
The model developed in this study identifies six modes related to the LVAD
adaptation process. In order to promote adaptation, clinical providers should be
knowledgeable regarding the various modes of each LVAD patient’s adjustment
processes. Clinical providers can assist patients through the various modes of adaptation
identified (e.g., physical, caregiver dependence, device management, roles, LVAD public
perception, and connection). For example, an understanding of a patient’s caregiver
dependence allows the LVAD team to provide patient-centric education regarding the
care of the device. Patient-centric education is critical if the patient has limited social
support or will be living alone. Additionally, providers can expedite teaching the patient
to perform LVAD dressing changes independently and monitor for clinical signs of
infection if the provider knows there is a strong desire to be independent and has a fear of
being a burden to caregivers. Also, younger LVAD patients that are planning to assume
the roles of college students may need special considerations regarding clinic
appointment scheduling in order to accommodate classes.
In this study, participants discussed a strong desire to connect with clinical
providers and other LVAD patients. Several of the participants described strong existing
connections with LVAD patients, reporting frequent contact and encouragement along
with participating in social activities together (e.g., golf, travel, and social activities). The
connection among LVAD patients provides the opportunity to express challenges and
frustrations as well as receive advice and recommendations in a safe, nonjudgement
environment. LVAD centers should provide opportunities for LVAD recipients to
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connect in order to establish friendships, exchange information, provide peer support, and
connect with others experiencing LVAD adjustment.
Patient Education
Overall, participants noted satisfaction concerning LVAD education and
preparation for the patient or caregiver to care for the device upon hospital discharge.
However, several participants mentioned a lack of preparation and even traumatic
experiences regarding aspects of cardiac surgery (e.g., intubation, intensive care unit
psychosis, post-surgical pain). Providers have the opportunity to optimize LVAD patient
education and include information regarding the cardiothoracic surgery, intubation, and
post-operative recovery.
Additional areas for patient education include how to modify clothing and LVAD
accessories (e.g., belts, vests, pants) to accommodate a patient's various activities. Male
and female participants also noted frustration regarding wearing the LVAD and external
equipment. It often takes a lengthy period and much trial and error for patients to achieve
personal ways to wear or carry LVAD equipment. This process has the potential to delay
or frustrate participants as they move through the LVAD adaptation process. Often
patients do not have access to try various ways to wear or carry LVAD equipment before
purchasing products. LVAD centers should consider investing in a variety of LVAD
equipment and accessories for education, and so patients may try on at clinic visits.
Optimizing the LVAD adaptation process has the potential to improve LVAD patient
satisfaction with the device and increase stabilization of the LVAD, thus preventing
mishaps (e.g., device drops, driveline exit site injuries, device malfunctions).
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Future Research
The findings of this study present several opportunities for further research. This
study identified the potential disconnect between the clinical LVAD implant indication
and the patient perception of the LVAD treatment trajectory. Of the participants, six
(30%) self-reported BTT, however, indicated they denied current heart transplant listing.
Research is needed to determine if participant perception aligns with the LVAD clinical
team perception of the participants’ perception and what factors are hindering
participants from being listed for transplant. This study also identified inconsistencies
regarding clinical care requirements (e.g., medication adherence, risks for infection)
regarding heart transplantation. For example, some participants discussed returning to
activities after heart transplantation that clinical providers might feel pose an increased
risk of infection (e.g., parks, activities with large crowds). Participants expressed the
desire for a heart transplant due to the ability to have increased energy, improved
tolerance to the heat, and extended life greater than ten years. Despite perception, there
are no guarantees that clinical outcomes after transplant will achieve the above. There is a
need to fully understand the LVAD patient’s perspective regarding motivation for heart
transplantation in order to establish realistic expectations.
Employment often fulfills one’s ability to contribute financially to one’s
household as well as provides a purpose for individuals. Limited research is available
regarding employment with an LVAD device. One study describes the challenges with
assisting younger LVAD patients to find occupations conducive to the LVAD as well as
helping other transition from the sick role into meaningful employment (Overgaard et al.,
2012). This study identified the loss of employment before receiving the LVAD due to
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AHF symptoms. Participants also varied in responses regarding an ability to return to
employment. Participants noted being employed previously in positions that presented
challenges to returning due to physical requirements (e.g., lifting heavy objects, driving
heavy machinery) and risks for driveline infection (e.g., exposure to weather, heat).
Participants who expressed the ability to return to work possessed similar occupational
characteristics: work that could be completed remotely from home. These flexible
schedules can accommodate frequent healthcare clinic visits and requiring little to no
physical requirements. However, occasionally participants who identified prior
occupations that met the above criteria did not return to work. It is essential to further
explore motivating factors regarding obstacles and barriers related to employment after
the LVAD. LVAD clinical providers should have an understanding of this vital
component of LVAD adjustment.
The study also depicts discrepancies among patient perceptions regarding
activities such as support system, driving, dressing change frequency, anticoagulation
management. Often these activities or inconveniences create frustration and more
significant challenges regarding LVAD adaptation. Incongruences regarding modes of
LVAD adjustment included the following: (a) living independently vs. being required to
have continual care provide (e.g., having to relocate to live with family), (b) center
recommendations regarding driving (e.g., physician approval to return to driving vs.
inability to drive at all), (c) frequency of driveline dressing changes (e.g., daily vs.
biweekly or weekly), (d) dietary recommendations (e.g., ability to eat vitamin K rich
foods vs. having to refrain from such foods), and (e) frequency, and convenience of lab
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monitoring (e.g., home INR monitoring). Further research and standardization of best
practices between LVAD centers could profoundly impact the LVAD adaptation process.
Strengths and Limitations
This study provided, to our knowledge, the first qualitative study to explore
LVAD adaptation and the patient perceived LVAD implant indication among participants
from two LVAD centers. Using study participants from two centers allowed researchers
the ability to confirm responses among participants and increase generalizability. The
semi-structured interview guide used Roy’s Adaptative Model (RAM) (Roy, 2009) as a
theoretical structure served as a strength of the study allowing the researchers to explore
the holistic approach to LVAD adjustment. The concepts derived from the study (e.g.,
caregiver dependence, device management, roles, LVAD public perception, connection,
and holistic person) varied from that traditionally described in RAM, the researchers
were able to develop a model more specific to the experiences of LVAD participants
regarding the adjustment experience.
The sample attempted to capture a similar demographic representation of the
Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS),
national LVAD data registry, in order to increase study applicability (e.g., 46% DT and
54% BTT in 2011-2014)(Kirklin et al., 2015). However, more participants identified as
BTT than one would anticipate based on the INTERMACS registry. Despite these
participants identifying as BTT, they self-reported they were not active on the transplant
waiting list, leaving room to question if these participants may have received an LVAD
as a DT implant indication at the time of device implant.
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A limitation of the study included a lack of confirmation regarding LVAD
implant indication, current transplant listing status, and specific factors contributing to
heart transplant ineligibility. Additionally, participants self-selected to be interviewed,
thus their overall health may be more optimal than other LVAD patients. Finally, the
sample consisted of BTT and DT participants; although we noted overall consistency in
responses regarding LVAD adjustment among the groups, other studies may discover
different findings.
Conclusion
Roles, public perception, and connection were significant to LVAD patients but
are often not addressed in this population. Results provided a basis for topics for further
exploration and study, such as how patients adapt to the LVAD without caregiver
support. This study identified the need for opportunities for LVAD patients to connect
with clinical providers and participate in activities with other LVAD patients. Topics
identified for further education among LVAD patients included the following: postsurgical care, showering/bathing, clothing, equipment options, travel, navigating security,
and an annual refresher for managing clinical complications. Finally, results provided a
basis for further qualitative exploration regarding the patient perspective of challenges in
transplant listing in BTT patients that have a delay in transplant listing.
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Table 1
Semi-structured guide for group and individual interviews.
Opening:
1. Please share your first name and how long you have had your LVAD, and if you
have ever had your LVAD replaced.
Transition:
2. How did you first come to learn about an LVAD?
Key Questions:
3. Can you share how the LVAD has impacted you physically? Psychologically?
4. Tell me how the LVAD has impacted your self-concept both positively and
negatively?
5. How did your family and friends initially respond to the LVAD?
6. What are some of the "roles" that you have among your family and professionally
(e.g., spouse, family member, parent, financial provider, caretaker)? Can you
share how the LVAD has impacted these roles?
7. Tell me about how the activities that require assistance from someone because of
the LVAD?
8. How has the LVAD impacted your activities of daily living?
9. How would it impact your life if you knew you were going to live with the LVAD
for the rest of your life?
Ending:
10. After having the LVAD for a period now, what information do you wish you
would have known before receiving the LVAD?
11. What information would you share with someone thinking about getting an
LVAD to best prepare them?

Note. Based on the interview structure outlined by (Crabtree & Miller, 2009) and
questions guided by the RAM (Roy, 2009)
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Table 2
Sociodemographic Characteristics of Participants
Characteristic
Age, mean
Black or African American
White
More Than One Race
Gender
Female
Male
Length of Time with LVAD
< 1 year
1 – 2 years
3 – 4 years
5 – 6 years
7 – 8 years
9 – 10 years
> 10 years
Device Type:
HeartMate IIa
HeartWareb
HeartMate 3c
Reason for LVAD:
BTT
DT
Marital status:
Single (never married)
Married
Widowed
Divorced
Separated
Education level
High school degree or equivalentd
Some college, no degreee
Bachelor’s degreef
Master’s degreeg
Professional degreeh
Employment Status:
Employed full timei
Employed part-timej
Unemployed and not currently looking for work
Student
Retired
Self-employed

Value (%)
57 years
8 (40%)
12 (60%)
2 (10%)
7 (35%)
13 (65%)
3
9
5
2
0
0
1

(15%)
(45%)
(25%)
(10%)
(0%)
(0%)
(5%)

5 (25%)
12 (60%)
3 (15%)
14 (70%)
6 (30%)
3
11
1
4
1

(15%)
(55%)
(5%)
(20%)
(5%)

5
8
4
1
2

(25%)
(40%)
(20%)
(5%)
(10%)

1
2
1
1
9
1

(5%)
(10%)
(5%)
(5%)
(45%)
(5%)
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Unable to work
Household Income
Less than $20,000
$20,000 to $34,999
$35,000 to $49,999
$50,000 to $74,999
$75,000 to $99,999
>$100,000
Did not disclose

5

(25%)

10
1
2
2
1
2
1

(50%)
(5%)
(10%)
(10%)
(5%)
(10%)
(5%)

Note. N = 20. LVAD, left ventricular assist device; BTT, Bridge-to-transplant; DT, Destination therapy;
a
HeartMate II®; b HeartWare® (HeartWare, Inc., Framingham, MA); cHeartMate3®
d
High school degree or equivalent (e.g., GED), eSome college, no degree, f Bachelor’s degree (e.g., BA,
BS), g Master’s degree (e.g., MA, MS, Med), h Professional Degree (e.g., MD, DDS, DV, Ph.D., EdD),
i
(40 or more hours per week); j(up to 39 hours per week)
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Table 3
Sociodemographic Characteristics and Recruitment Site of Participants
Screening
Site

Age

Gender

Race

LVAD Device

Marital
Status

Education
Level

HeartMate II®, a

Length of
Time on
Device(s)
5-6 yrs.

MH-TMC

64

Male

Black

Divorced

Some collegee

MH-TMC

55

Female

White

HeartWare®, b

1-2 yrs.

Divorced

High schoolf

MH-TMC
BSLMC
BSLMC

70
64
57

Male
Male
Male

Whited
White
Black

HeartWare®, b
HeartWare®, b
HeartMate 3®, c

1-2 yrs.
3-4 yrs.
1-2 yrs.

Married
Married
Married

Some collegee
Professionalg
Some collegee

MH-TMC

62

Female

Black

HeartWare®, b

5-6 yrs.

Divorced

Bachelor’sh

Black

®, b

Current
Employment
Status
Retired

MH-TMC
MH-TMC

23
39

Female
Female

Black
White

HeartWare
HeartWare®, b

1-2 yrs.
1-2 yrs.

Single
Married

Some college
Some collegee

Unable to
work
Retired
Retired
Selfemployed
Unable to
work
Unable to
work
Student
Employed PT

MH-TMC

62

Male

White

HeartMate II®, a

3-4 yrs.

Married

Some collegee

Retired

BSLMC
BSLMC
BSLMC

61
68
47

Male
Male
Female

Black
Blackd
White

HeartMate 3®, c
HeartWare®, b
HeartWare®, b

< 1 yr.
< 1 yr.
1-2 yr.

Divorced
Married
Separated

High schoolf
Bachelor’sh
Some collegee

BSLMC
MH-TMC

46
49

Female
Male

White
Black

HeartMate II®, a
HeartMate II®, a

3-4 yrs.
3-4 yrs.

Single
Married

Bachelor’sh
High schoolf

BSLMC

66

Male

White

HeartWare®, b

1-2 yrs.

Married

Master’s i

Retired
Employed FT
Unable to
work
Retired
Unable to
work
Retired

BSLMC
BSLMC

74
73

Male
Male

White
White

HeartWare®, b
HeartWare®, b

1-2 yrs.
1-2 yrs.

Married
Married

Professionalg
Bachelor’sh

Employed PT
Retired

MH-TMC
MH-TMC

66
34

Female
Male

White
White

HeartMate II®, a
HeartMate 3®, c

3-4 yrs.
< 1 yr.

Widowed
Married

High schoolf
Some collegee

Retired
Unemployedj

BSLMC

54

Male

HeartWare

®, b

> 10 yrs.

Single

High school

f

e

Income

$35,000 to
$49,999
< $20,000

S-R
Indication
& Listing
BTT – (L)
BTT – (L)

< $20,000
> $100,000
$20,000 to
$34,999
< $20,000

BTT – (L)
BTT – (L)
BTT – (L)

< $20,000

BTT – (L)

< $20,000
$75,000 to
$99,999
Did not
disclose
< $20,000
> $100,000
< $20,000

BTT – (L)
BTT – (L)

< $20,000
< $20,000

BTT – (NL)
DT

$35,000 to
$49,999
> $100,000
$50,000 to
$74,999
< $20,000
$50,000 to
$74,999

DT

BTT – (L)

BTT – (NL)
BTT – (NL)
BTT – (NL)
BTT – (NL)

DT
DT
DT
DT

Note. N=20. LVAD, left ventricular assist device; S-R Implant & Listing, Self-Reported Implant Indication
& Listing Status; MH-TMC, Memorial Herman – Texas Medical Center, Houston, TX; BSLMC, Baylor St.
Luke’s Medical Center, Houston, TX; PT, Part-Time; FT, Full-Time; BTT, Bridge-to-transplant; (L),
Listed for heart transplant; (NL), Not listed for heart transplant; DT, Destination therapy
a
HeartMate II®; b HeartWare® (HeartWare, Inc., Framingham, MA); c HeartMate 3®
d
Identified as More than one race, e Some college, no degree, f High school degree or equivalent (e.g.,
GED), g Professional Degree (e.g., MD, DDS, DV, Ph.D., EdD), h Bachelor’s degree (e.g., BA, BS), i
Master’s degree (e.g., MA, MS, Med), j Unemployed and not currently looking for work.
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Table 4
Living with the LVAD: A Second Chance at Life participant exemplars.
Illness
Perception

AHF

Community
Care

Introduction
to an LVAD

Limited
Choice

"I went from gasping from breath and not being able to do
a lot of things. Like, I could get out to the driveway and
get my newspaper and come back in; that was it. That was
my eight-hour job for the day." [Participant 26]
"I developed breast cancer, and then the second year, I
developed breast cancer again. And after that, the doctor
did tell me that I will---with all the chemo, it weakened
my heart and that eventually, I would be needing some
kind of heart treatment or et cetera.” [Participant 3]
"They wouldn't listen to me. It was, you just need to lose
the weight, and it'll fix itself. You need to lose the
weight; it'll fix itself. No, you're not hearing me, there's
something wrong with me…This [LVAD] is
unknown…Y’all deal with it every day. This [the LVAD]
is a common occurrence for you all. For us, it's not…It's
not out there at all [community LVAD knowledge]."
[Participant 46]
“Well, first of all, they wanted me to decide. I had to go
home for a couple of weeks and sit on the front porch and
pray and figure it out with God, and I decided that it was
the route to go because they [family] all wanted me to stay
around a while.” [Participant 20]
"And I thought I was just going in to ask questions you
know, to—you know, just the routine…checkup thing—
just routine questions and stuff. And it didn't happen like
that. The same day that I had the appointment with him,
he put me in [hospitalized]. I mean, you know, he told me
about the LVAD, but that very day he put me in. And
total, after the operation and everything else, I was in
there for a little over three months. That’s how I found out
about it [an LVAD].” [Participant 42]
"I was told I need an LVAD; I was reluctant against it.
And, [cardiologist], she had to talk me into getting one.
So, after she made me realize things [my grandkids and
my three boys], then I went on and agreed with it"
[Participant 45].
“And then, of course, after I’m in the hospital and I’m
going downhill pretty fast, you know, where they can’t get
me out of AFib. And basically, I’m just really feeling bad.
And then they tell me, well, we can do-, we can do this.
And frankly, that’s your only choice. You know? So, it
was an easy decision for me to make. I had no qualms
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Cardiac
Surgery
Recovery

LVAD
Adjustment

Health
Aspirations

about going through with it because if it was my only
chance, you know, I feel like I’ve got a lot of things that I
want to see and do” [Participant 37].
"When they told me that they were going to have to put a
tube down—a breathing tube down me, and I kind of
freaked out, and she said, 'Oh, no, it will be removed
before you wake up.' I was not prepared for what
happened because all I knew—I didn't think about the
tube—all I knew is that I couldn't breathe, nobody was in
there, I couldn't remember where I was. There were no
nurses, no family, no nothing. And, like I said, it was only
a couple minutes at a time, maybe a couple of seconds at a
time, that I would come to. But each time that it
happened, it was the same thing. And honestly, I
thought—that I was in some madman's house chained up
because I couldn't move my hands. They were tied down.
And they didn't tell me that I was going to happen either"
[Participant 42].
“So, you know, I've gotten used to it now, and I've come
to realize that, you know, I think, if I hadn't had got it, I
don't think I'd been here now. I don't know. It's been an
experience. So, I'm good to go for right now.”
[Participant 2]
“That was the whole point of getting the surgery. That
was the reason behind letting them put a steel titanium
pump in my heart, getting on the golf course. "And what
about your family?" I said, ‘Well, here it is, golf course,
dog, wife, and kids. Sorry. That's priority.’” [Participant
26]
“The destination was not leaving the hospital alive
without it. So I said, hook me up.” [Participant 47]
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Table 5
LVAD adjustment components and participant exemplars
Physical
Activity

Caregiver
Dependence

Self-care

Roles

“As far as the LVAD, I would say, within a week or two, I was doing
pretty much anything I wanted to, even taking, you know, doing showers
and stuff by myself, which I couldn’t before” [Participant 2].
“It made things easier for me to do around the house. So, it took a while
for me to get back to my normal routines…maybe two years to get back
at 100. Maybe two years…but I’m okay now” [Participant 45].
“My wife has, kind of, taken the brunt of that just since being a nurse and
doing most of every-, pretty much doing all of the actual care for the
driveline, things like that.” [Participant 44]
“That [LVAD] has changed my independence because they’re—my
family, we’re a very close family, so, you know, they want to make sure
that, you know, I’m in good hands at all times” [Participant 3].
"I don't like to be in a lot of crowds because of the wire hanging out
[driveline], you know, because somebody could bump it, especially kids
or stuff." [Participant 3]
“I have two adapters at the house. I could sit and watch TV, or I can lay
in bed and hook the adapter to it” [Participant 20].
"It's like 8 pounds or maybe 10, and it's a little difficult sometimes
because you get tired easier. You're already running on a certain level,
and then with this, it tacks onto it”[ Participant 32].
"My shower went from 30 minutes too, now, an hour, and hour and 20
minutes by the time you wrap and make sure everything is just right and
secure stuff" [Participant 37].
"Yeah, I—you know, that's a process that's just too time-intensive. It's
easier for me to take a hospital-type bath, you know. I'll get in front of
the sink and strip completely naked and do that all right there and
shampoo my hair—the whole thing, and I've found that to be more
efficient than encapsulating myself to take a traditional shower, you
know. Yeah, it's a pain" [Participant 39].
"I can't wear a dress unless I get it special made. I can't wear heels…I've
adjusted. You know, I just have to wear pants. I can wear a skirt and a
top, anything two-piece. I can't wear like I said, a dress" [Participant 45].
"I've only driven once since having LVAD…Safety just because of
having, then having to re-fix the sternum wiring once, going to have to
go through that surgery again [transplant]. And also, just-, I’m a shorter
statured guy. How close to the steering wheel I am, even to have a pillow
there, it was very discomforting” [Participant 44].
"Participant in family matters, get-togethers, doing stuff around the
house, shredding, working, it just started to decrease and decrease and
decrease, and then, once I got the LVAD, this all started coming back in
place…So, it's, kind of, just rebuilding my life back slowly. And, I can't
get out there and work all day long, but if the weather's right, if it's cool,
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I can get out there and work for several hours, where I couldn't do
anything hardly, not even walking to the car. I just had to stop, sit down,
walking to the car" [Participant 20].
"My grandkids, you know, they don't know. One of them, she was still
hopping in my lap and stuff, you know. I just had to put her on this
Participant e and let her know she can’t sit on my left Participant e”
[Participant 45].
“I didn’t realize what I had when I was so sick, but I had to retire several
years before this came up” [Participant 2].
“I can’t go back to the career I was just because it’s lifting heavy bags of
coffee” [Participant 44].
LVAD
“I don’t care what people say or look or how—about me, so I’m not that
Public
type of a person” [Participant 3].
Perception
“As far as like going places, with all the crime and stuff, I’m so worried
about [someone] thinking it’s a purse, you know, and yank it off my
body.” [Participant 3].
"I've often wondered, I've often thought… Am I going to walk in a place,
and they're going to be freaking out thinking I've got bombs on me
because I've got a strap and these [batteries]." [Participant 42]
Connection “When I go get my blood taken, in the store, anybody I talk to when the
subject [LVAD] comes up, I tell them, ‘Do not hesitate to get it, whether
it’s permanent or it’s getting in line for a transplant.’ I just, I would
recommend to any and everybody for the LVAD now that I’ve been in it
this long.”
Holistic Self “The true reason [to receive the LVAD] was to get on the golf course.
That’s my normal” [Participant 26].
"Before I had the surgery, I could go to the grocery store, and I could,
one, pick out the groceries, or I could put the groceries on the conveyor
belt. Or, if someone else did the first and second thing, I could put them
in the car. If someone else did the first three things, then I could take
them from the car to the house. I could not do all four things…And,
once I had the LVAD, I could do all four things, and the first time I could
do all four things, I cried. I was just like, “I’m normal” [Participant 50].
"Not being able to, kind of, be myself, drive, things like that has felt like
a little setback sometimes. And so…" [Participant 44].

80

Table 6
Implant indication exemplar comparison of Holistic Person and Health Aspirations
SelfReported
Implant
Indication
BTT

Holistic Person

Health Aspirations

“I told XXX [Cardiologist] two
years ago, "I won't be getting an
organ… I said, "Dr. XXX, I did a
lot of gambling. I've gambled all
my life, for 17 years—sports
gambling, I know the odds.”
[Participant 26]
"It's like getting out of your car,
and you park in the handicap, and
somebody starts yelling at you. I
used to carry the letter that says I'm
on the transplant list. But I can't
quell their anger." [Participant 26]
"For me, when I first, you know—I
won't say when I first got it—after I
got, after I was put on the
transplant list, I just always come
in here and cried to XXX
[Cardiologist], because, somebody
had to die in order for me to get a
transplant, somebody has to lose
their life. I wish they could find
another way that you could get a
transplant, but I know they can't."
[Participant 45]
"A lot of people don't understand
when you say that you question
whether you want a transplant
because—I'm a single woman. I
don't have any children. I don't
have any family. There are people,
and lots of them, that have
situations where they have people
that are dependent on them, and
they're trying to get a heart, and
that heart would benefit not just
them, but the other people in their
family, and impact other families.

“I'm a public speaker. My story's not
complete. I want to have a full story.“
[Participant 26]
“I’m looking forward to it [heart
transplant]…Maybe go back to work
because I don’t like being at home.
I’ve very active” [Participant 3]
“Well, just to go fishing more, not
necessarily swimming, but at least
going fishing and just living in
general…Just family altogether…If I
get the transplant and if it agrees with
me, I can see me, see us, you know,
barbequing and having holidays meals
and stuff, get-togethers, going fishing,
maybe getting on the tractor and
going, you know, a little bit in the
pasture, different things like
that…Enjoy animals. I mean, I do that,
but right now, my wife is helping to do
more part of my share." [Participant
20]
"My grandkids. My grandkids. I'll be
able to go places with them, like go to
the zoo, go to the park, you know, I'd
just be able to enjoy them. Yeah. It'd
be a big weight off of me…Because, I
get tired, you know, from walking with
it [LVAD] so long. Yeah. Like, I want
to go to Disney World with them, but I
can't take the heat. So, you know, all
this medicine I'm on, I can't take the
heat. And then, like, when you take
different trips and stuff, you have to
pack all this equipment and stuff. You
know, it's not just like packing a
suitcase and, okay, you go. You've got
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DT

And so, if you look at the big
picture, if I got a heart, it just
impacts me. If they got a heart, it
impacts them and their children and
their children, and it goes on and on
and on. So, it's kind of, like who
am I to take that away from them.
So, now, if I say that out loud,
some people get upset. "Well, no.
You deserve that too." [Participant
50]
"I thought I compromised my
beliefs a little bit just because it
was-, it's still a struggle thing and a
machine, a mechanical thing is
pumping my heart for me,
basically. And then, you know,
after getting transplanted in a few
years, even if it has you back on
breathing machines and stuff like
that..." [Participant 44]
“I put, as far as living or dying, I
put that in God's hands, and I put
all the decision-making, medical,
and educational part in the doctor's
hands.” [Participant 20]
"Well, in my case, they wouldn't
give me a heart, and the distilled
version was, 'well, you've got
uncontrolled diabetes,' which is
actually not true. I can routinely
keep it under 200, routinely. And,
sometimes, if I'm really diligent, at
100. But what they can't tell you or
won't tell you is, you're too old.
Because they'd have the old people
union on them, right? There'd be
pitchforks out front—they'd be
wanting to burn the building down,
so they cannot say you're too old.
But, in my case, that's exactly what
it was." [Participant 39]
“During the time I was going
through the process of getting on a
heart transplant, they told me about
the possibility of a bridge, you

to pack all your equipment, all your
medicine, and stuff" [Participant 45].

"But many people on LVADs when
their opportunity comes up to get a
replacement heart, or a transplant, I
said, well, they turned it down because
truthfully this thing's really not that
big of a pain in the butt and I was
somewhat shocked to find out that the
average life span with a transplanted
heart is ten years, ten years. So, if you
think about it, I would expect to live
longer with this thing than ten years. I
mean, I think so." [Participant 39]
“And, you know, I had hopes that this
thing is not going to be just a 10-year
deal for me. Because, you know,
because of the fact that they have told
me that my heart is otherwise good. I
mean, basically, my electro
cardiologist said, you know, he was in
there. And he said, your heart looked
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know, to transplant type situation.
But then once I ended up going
through the cancer situation, they
told me I was going to be too old.
And that it would end up being a
destination deal for me. I mean,
they never say never. But, you
know, they said, you know, likely
you’re going to be too old when-,
you know, because you’re going to
have to be free of cancer for three
years basically. And then you’re
going to be too old. You know?
I’ll be 75 at that time.” [Participant
37]
"I think they're full of crap. As far
as the hearts go, because they're
like, 'oh, you've got to have this
under control, and this needs to be
did.' Why am I sitting here
jumping through all these damn
hoops, you know? I quit smoking,
started losing weight, started taking
my calcium pills because of the
osteoporosis, which was caused by
the medicine they gave me, to
begin with, so. . . I'm not trying to
do it for battle. A year and a half
trying to get on the transplant list,
I'm like . . . it don't make sense to
try to go through all this."
[Participant 1]
"So, right now, I'm currently
labeled as destination. But, kind
of, just my BMI is too much for, to
be listed right away. So, we did a
gastric sleeve at the same time. So,
right now, I started at a weight of
340. Now I'm down to right
around 275. So, once I hit, I did
220, 200-pound mark, we will start
actively looking at more being on
the list at that point." [Participant
44]
“It was my choice because, like I
said, I'm not strong enough to be

pristine. And as a matter of fact, they
had checked. And they said the one
area of the heart that had had the
issues with the electrical impulses, he
said, it’s still active. And he thought
there was a chance that my heart-, you
know, I’d be among the few, relatively
few that my heart would heal. But, of
course, I talked to Doctor XXX
[Cardiologist], and he says, well,
because of your age, we’re not going
to turn it off [LVAD explant] or mess
with it or whatever, you know,
because it’s working.” [Participant 37]
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able to push everything away. And
if you're not strong enough, you
know, like I said, if you can't do it,
then you're wasting someone else's
heart. And I just don't want to do
that. And I feel comfortable with
my decision and—because, I mean,
if I took that heart knowing that I
wasn't strong enough to finish it,
so..." [Participant 42]
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Left Ventricular Assist Device Adjustment ImpacteD by Assigned Patient
Trajectory (LVAD-ADAPT): A Qualitative Exploratory Study
Interview Guide

Introduction
 Welcome by the PI and co-investigator
 Present purpose of the study
 Review reason for audio recording and note-taking
 Discuss informed consent
 Discuss confidentiality by researchers and participants
 Discuss group interview and discussion etiquette (respect and consideration
of others, one speaker at a time)
 Request completion of the “Demographic Survey Form”
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Semi-Structured Interview Guide for Left Ventricular Assist Device Adjustment ImpacteD by
Assigned Patient Trajectory (LVAD-ADAPT): A Qualitative Exploratory Study
Principal Investigator Brittany Rhoades, APRN, PhD Candidate,
The University of Texas Health Science Center at Houston Cizik School of
Nursing
Semi-Structured Guide Questions (Q)
Q1

How did you first come to learn about a Left Ventricular Assist Device
(LVAD)?

Q2

Can you tell me how the LVAD impacted you physically? Psychologically?

Q3

Can you tell me about how the LVAD impacted your self-concept
(positively and negatively)?

Q4

Can you tell me about some of the roles that you have among your family
and professionally? How did the LVAD impact these roles? (e.g., spouse,
family member, parent, financial provider, care taker, etc.)

Q5

How did your family and friends respond to the LVAD?

Q6

Can you tell me a little about the activities that require assistance from
someone because of the LVAD?

Q7

Can you tell me how the LVAD impacted your activities of daily life?

Q8

What information would you give to best prepare someone for an LVAD?

Q9

How does the LVAD impact your plans?
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Interview Probing Questions Guide for Left Ventricular Assist Device Adjustment ImpacteD by
Assigned Patient Trajectory (LVAD-ADAPT): A Qualitative Exploratory Study
Principal Investigator Brittany Rhoades, APRN, PhD Candidate,
The University of Texas Health Science Center at Houston Cizik School of
Nursing
Semi-Structured Guide Probes (P)
P1

Recall the first time that you were informed you were going to need an
LVAD? Describe how learning that you need an LVAD made you feel.

P2

What were you able to do that you could not do prior to the LVAD? Were
there activities that the LVAD hindered you from participating?

P3

What helped you adjust to living with the LVAD?

P4

Please describe your “role” within your family or your family dynamics.
How did the LVAD impact your role within your family? Can you describe
your occupation or professional role? How did the LVAD impact this role?

P5

Tell me about the how your family responded when they first encountered
your LVAD? What was it like to participate in social activities with the
LVAD?

P6

Overall, as time increases what activities have you become more
independent because of the LVAD?

P7

What activities do you find most challenging since LVAD implantation?
What activities were better with the LVAD?

P8

What information do you wish you would have known before implant
regarding living with the LVAD? How would knowing this information
have impacted your adjustment to your LVAD?

P9

What do you look forward to being able to do now that you have an
LVAD? What activities are you disappointed that you cannot participate or
achieve due to your LVAD?
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